GlassScriptPhysician profile
Steven Brandwein
NPI 1174542450
$1,826.55
in general payments reported to CMS, 2019-2025
10 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $144 · 2021: $65.93 · 2022: $323 · 2023: $293 · 2024: $153 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $796.90 | 2020-2025 | Skyrizi, Rinvoq |
| Boston Scientific Corporation | $353.13 | 2019-2023 | |
| Cook Medical LLC | $178.70 | 2022 | |
| Janssen Biotech, INC. | $150.00 | 2025 | Tremfya |
| Madrigal Pharmaceuticals | $149.00 | 2025 | Rezdiffra |
| Pfizer INC. | $122.92 | 2019 | |
| Array Biopharma INC | $32.88 | 2019 | |
| Erbe USA INC | $16.28 | 2019 | |
| Shire North American Group INC | $14.85 | 2019 | |
| Allergan, INC. | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Brandwein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.